Management of immune checkpoint inhibitor‐related adverse events: A review of case reports

Immune checkpoint inhibitors represent a major breakthrough in cancer therapy. Immune‐related adverse events (irAEs) may occur during treatment due to their unique mechanism of action. Management of irAEs is based on clinical experience because it is not easy to conduct prospective trials to evaluat...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Thorac Cancer
Hoofdauteurs: Si, Xiaoyan, Song, Peng, Ni, Jun, Di, Mingyi, He, Chunxia, Zhang, Li, Liu, Xiaowei, Li, Yue, Wang, Hanping, Guo, Xiaoxiao, Zhou, Jiaxin, Duan, Lian, Yang, Xu, Wang, Mengzhao
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley & Sons Australia, Ltd 2020
Onderwerpen:
Invited Review
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7049490/
https://ncbi.nlm.nih.gov/pubmed/31970923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13315
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items